[go: up one dir, main page]

ES2047451A1 - Procedimiento para la preparacion de una composicion farmaceutica oral estable. - Google Patents

Procedimiento para la preparacion de una composicion farmaceutica oral estable.

Info

Publication number
ES2047451A1
ES2047451A1 ES9201425A ES9201425A ES2047451A1 ES 2047451 A1 ES2047451 A1 ES 2047451A1 ES 9201425 A ES9201425 A ES 9201425A ES 9201425 A ES9201425 A ES 9201425A ES 2047451 A1 ES2047451 A1 ES 2047451A1
Authority
ES
Spain
Prior art keywords
coating
insulating layer
prepn
stable pharmaceutical
soluble insulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9201425A
Other languages
English (en)
Other versions
ES2047451B1 (es
Inventor
Rueda Moreno
Rovira Bosch
Vidal Canals
Ges Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES9201425A priority Critical patent/ES2047451B1/es
Publication of ES2047451A1 publication Critical patent/ES2047451A1/es
Application granted granted Critical
Publication of ES2047451B1 publication Critical patent/ES2047451B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA ORAL ESTABLE. EL PROCEDIMIENTO CONSISTE EN SUSPENDER EL LANSOPRAZOL (FORMULA I) EN UNA SOLUCION ACUOSA DE FOSFATO DISODICO Y LAURILSULFATO SODICO, AMASAR CON LA MISMA EL RESTO DE EXCIPIENTES, GRANULAR Y ESFERONIZAR, RECUBRIR EL GRANULADO CON UNA CAPA AISLANTE SOLUBLE Y FINALMENTE RECUBRIR CON UNA CAPA ENTERICA. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES GASTROINTESTINALES.
ES9201425A 1992-07-10 1992-07-10 Procedimiento para la preparacion de una composicion farmaceutica oral estable. Expired - Fee Related ES2047451B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9201425A ES2047451B1 (es) 1992-07-10 1992-07-10 Procedimiento para la preparacion de una composicion farmaceutica oral estable.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9201425A ES2047451B1 (es) 1992-07-10 1992-07-10 Procedimiento para la preparacion de una composicion farmaceutica oral estable.

Publications (2)

Publication Number Publication Date
ES2047451A1 true ES2047451A1 (es) 1994-02-16
ES2047451B1 ES2047451B1 (es) 1994-10-01

Family

ID=8277598

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9201425A Expired - Fee Related ES2047451B1 (es) 1992-07-10 1992-07-10 Procedimiento para la preparacion de una composicion farmaceutica oral estable.

Country Status (1)

Country Link
ES (1) ES2047451B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192929A1 (es) * 2001-04-06 2003-10-16 Belmac S A Lab Procedimiento mejorado para la obtencion de pellets de omeprazol estables y gastrorresistentes, pellets asi obtenidos y aplicaciones.
EP1852100B1 (en) * 2005-02-25 2018-05-09 Takeda Pharmaceutical Company Limited Method for producing coated granules of a benzimidazole compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604929A1 (es) * 1985-02-05 1986-02-16 Tamarang S A Procedimiento para la obtencion del 2-(2-(3,5-dimetil-4-me- toxi)piridilmetil sulfonil)-5-metoxibenzimidazol
ES8609306A1 (es) * 1985-10-29 1986-04-01 Fordonal Sa Procedimiento de preparacion de un derivado del benzimidazol
ES2001389A6 (es) * 1985-08-24 1988-05-16 Hoechst Ag Procedimiento para preparar derivados de o-toluidina

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604929A1 (es) * 1985-02-05 1986-02-16 Tamarang S A Procedimiento para la obtencion del 2-(2-(3,5-dimetil-4-me- toxi)piridilmetil sulfonil)-5-metoxibenzimidazol
ES2001389A6 (es) * 1985-08-24 1988-05-16 Hoechst Ag Procedimiento para preparar derivados de o-toluidina
ES8609306A1 (es) * 1985-10-29 1986-04-01 Fordonal Sa Procedimiento de preparacion de un derivado del benzimidazol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192929A1 (es) * 2001-04-06 2003-10-16 Belmac S A Lab Procedimiento mejorado para la obtencion de pellets de omeprazol estables y gastrorresistentes, pellets asi obtenidos y aplicaciones.
EP1852100B1 (en) * 2005-02-25 2018-05-09 Takeda Pharmaceutical Company Limited Method for producing coated granules of a benzimidazole compound

Also Published As

Publication number Publication date
ES2047451B1 (es) 1994-10-01

Similar Documents

Publication Publication Date Title
JP3699122B2 (ja) 新規な経口用の医薬使用形態
IL109245A (en) Veterinary composition in the form of a pastelike gel containing enteric coated beads or tablets of a proton pump inhibitor compound
ZA200205512B (en) Novel substituted benzimidazole dosage forms and methods of using same.
EE03157B1 (et) Omeprasooli enantiomeerid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
PT977557E (pt) Formulacao granular para o tratamento do tracto intestinal
MY102675A (en) Pharmaceutical formulations of acid labile substances for oral use.
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
KR20010040819A (ko) 제어방출형 제제
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
EP0136103B1 (en) Amosulalol hydrochloride long acting formulations
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
CA2283297A1 (en) New formulation
PL332249A1 (en) Pharmaceutical microspheres of varproinic acid for oral administration
PL299376A1 (en) Method of making solid dosage units of controllable release
EP1624869A2 (en) Dosage form containing pantoprazole as active ingredient
ES2047451A1 (es) Procedimiento para la preparacion de una composicion farmaceutica oral estable.
AR245125A1 (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y sus sales de adicion de acidos farmaceuticamente aceptables.
CA2105541A1 (en) Programmed Release Tablets Containing Naproxen
EP1004297A1 (en) Pharmaceutical compositions for oral administration containing a gastroresistant coating based on acrylic polymers
IT8747546A0 (it) Procedimento per la preparazionedi microsfere gastroresistenti ed enterosolubili di enzima digestivo e preparato farmaceutico a microsfere cosi' prodotto
CA2582299A1 (en) Oral pharmaceutical preparation for proton pump antagonists
EP0383481A3 (en) Anesthetic oral compositions
HU9902562D0 (en) Plaster for ingestion of therapeutical compounds into live organism and process for producing thereof
ZA848894B (en) New galemic forms of sulpiride for oral administration

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120